Known targets — ChEMBL curated mechanism
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
The experimentally established mechanism targets of Phosphoric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC34A1 | Q06495 | 1/20 | 0.73 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.47 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 2/20 | 0.47 |
| ▸ | CA2 | P00918 | 1/20 | 0.39 |
| ▸ | CA1 | P00915 | 2/20 | 0.37 |
| ▸ | CA4 | P22748 | 2/20 | 0.37 |
| ▸ | CA5A | P35218 | 2/20 | 0.37 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.37 |
| ▸ | MMP2 | P08253 | 1/20 | 0.33 |
| ▸ | THRB | P10828 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | FDPS | P14324 | 1/20 | 0.33 |
| ▸ | BLM | P54132 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phosphoric Acid SCHEMBL9256279 | 1.00 | SLC34A1 (0.73) | SLC34A1KDM4ECYP2C19KMT2ALMNA | |
| Phosphoric Acid SCHEMBL935357 | 1.00 | SLC34A1 (0.73) | SLC34A1KDM4ECYP2C19KMT2ALMNA | |
| Phosphoric Acid SCHEMBL7762283 | 1.00 | SLC34A1 (0.73) | SLC34A1KDM4ECYP2C19KMT2ALMNA | |
| Phosphoric Acid SCHEMBL4754839 | 1.00 | SLC34A1 (0.73) | SLC34A1KDM4ECYP2C19KMT2ALMNA | |
| Phosphoric Acid SCHEMBL4619306 | 1.00 | SLC34A1 (0.73) | SLC34A1KDM4ECYP2C19KMT2ALMNA | |
| Phosphoric Acid SCHEMBL28240907 | 1.00 | SLC34A1 (0.73) | SLC34A1KDM4ECYP2C19KMT2ALMNA | |
| Phosphoric Acid SCHEMBL391749 | 1.00 | SLC34A1 (0.73) | SLC34A1KDM4ECYP2C19KMT2ALMNA | |
| Phosphoric Acid SCHEMBL10692716 | 1.00 | SLC34A1 (0.73) | SLC34A1KDM4ECYP2C19KMT2ALMNA | |
| Phosphoric Acid SCHEMBL7765982 | 1.00 | SLC34A1 (0.73) | SLC34A1KDM4ECYP2C19KMT2ALMNA | |
| Phosphoric Acid SCHEMBL3400141 | 0.95 | SLC34A1 (0.67) | SLC34A1KDM4ECYP2C19KMT2ALMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-106416496-A | Fertilizing method for crops planted under plateau photovoltaic panels | 云南省能源研究院有限公司 | 2017-02-22 | — | — | CN | claimed |
| CN-1206187-C | Building material prepared by mercury sludge conversion treatment and preparation method thereof | WU WEIWEN (CN) | 2005-06-15 | — | — | CN | claimed |
| CN-1186292-C | Catalytic coagulant for converting solid waste into building material and application thereof | WEIWEN WU (HK) | 2005-01-26 | — | — | CN | claimed |
| CN-1420099-A | Catalytic coagulant for converting solid waste into building material and application thereof | WEIWEN WU (HK) | 2003-05-28 | — | — | CN | claimed |
| CN-1418843-A | Building material prepared by mercury sludge conversion treatment and preparation method thereof | WEIWEN WU (HK) | 2003-05-21 | — | — | CN | claimed |
| CN-106416496-A | Fertilizing method for crops planted under plateau photovoltaic panels | 云南省能源研究院有限公司 | 2017-02-22 | — | — | CN | disclosed |
| EP-1750670-A1 | BUCCAL, POLAR AND NON-POLAR SPRAYS CONTAINING PROPOFOL | Novadel Pharma Inc. (US) | 2007-02-14 | — | — | EP | disclosed |
| EP-1696876-A2 | BUCCAL, POLAR AND NON-POLAR SPRAY CONTAINING ALPRAZOLAM | Novadel Pharma Inc. (US) | 2006-09-06 | — | — | EP | disclosed |
| EP-1682090-A1 | BUCCAL, POLAR AND NON-POLAR SPRAY CONTAINING ONDANSETRON | Novadel Pharma Inc. (US) | 2006-07-26 | — | — | EP | disclosed |
| EP-1675568-A1 | BUCCAL, POLAR AND NON-POLAR SPRAY CONTAINING ZOLPIDEM | Novadel Pharma Inc. (US) | 2006-07-05 | — | — | EP | disclosed |
| EP-1675566-A1 | BUCCAL, POLAR AND NON-POLAR SPRAY CONTAINING DIAZEPAM | Novadel Pharma Inc. (US) | 2006-07-05 | — | — | EP | disclosed |
| EP-1675567-A1 | BUCCAL, POLAR AND NON-POLAR SPRAY CONTAINING SUMATRIPTAN | Novadel Pharma Inc. (US) | 2006-07-05 | — | — | EP | disclosed |
| WO-2004019903-A1 | BUCCAL, POLAR AND NON-POLAR SPRAY OR CAPSULE CONTAINING DRUGS FORTREATING METABOLIC DISORDERS | NOVADEL PHARMA INC. (US) | 2004-03-11 | — | — | WO | disclosed |
| WO-2004019911-A2 | BUCCAL, POLAR OR NON-POLAR SPRAY OR CAPSULE CONTAINING DRUGS FOR TREATING ENDOCRINE DISORDERS | NOVADEL PHARMA INC. (US) | 2004-03-11 | — | — | WO | disclosed |
| WO-2004019910-A2 | BUCCAL, POLAR AND NON-POLAR SPRAY OR CAPSULE CONTAINING DRUGS FOR TREATING DISORDERS OF THE GASTROINTESTINAL TRACT OR URINARY TRACT | NOVADEL PHARMA INC. (US) | 2004-03-11 | — | — | WO | disclosed |
| WO-2004019912-A2 | BUCCAL, POLAR OR NON-POLAR SPRAY OR CAPSULE CONTAINING DRUGS FOR TREATING AN INFECTIOUS DISEASE OR CANCER | NOVADEL PHARMA INC. (US) | 2004-03-11 | — | — | WO | disclosed |
| WO-2004019904-A1 | BUCCAL, POLAR AND NON-POLAR SPRAY OR CAPSULE CONTAINING DRUGS FOR TREATING ALLERGIES OR ASTHMA | NOVADEL PHARMA INC. (US) | 2004-03-11 | — | — | WO | disclosed |
| WO-2004019905-A1 | BUCCAL, POLAR AND NON-POLAR SPRAY OR CAPSULE CONTAINING DRUGS FOR TREATING MUSCULAR AND SKELETAL DISORDERS | NOVADEL PHARMA INC. (US) | 2004-03-11 | — | — | WO | disclosed |
| CN-1420099-A | Catalytic coagulant for converting solid waste into building material and application thereof | WEIWEN WU (HK) | 2003-05-28 | — | — | CN | disclosed |
| CN-1418843-A | Building material prepared by mercury sludge conversion treatment and preparation method thereof | WEIWEN WU (HK) | 2003-05-21 | — | — | CN | disclosed |